跳至主要内容
临床试验/CTRI/2015/01/005378
CTRI/2015/01/005378Other未知

A cumulative skin irritation study evaluating the skin irritancy potential of topical analgesicVovilup spray containing a combination of diclofenac, menthol, methyl salicylate and linseedoil and comparing it with a marketed formulation-Iodex Ultragel.

GSK Consumer Healthcare0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
Other
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Healthy male or female volunteers aged atleast 18 years.
  • 2. Good general, physical and mental health in the opinion of the investigator or
  • medically qualified designee:
  • a) No clinically significant and relevant abnormalities in medical history or upon
  • physical examination.
  • b) Absence of any condition that could affect the volunteerâ??s safety or wellbeing or
  • their ability to understand and follow study procedures and requirements.
  • 3. Healthy volunteers who do not have excessive hair on the volar aspect of the
  • forearm(s).
  • 4. Healthy volunteers should understand and be willing to fully comply with all study
  • procedures and restrictions.
  • 5. Demonstrates understanding of the study and willingness to participate as evidenced
  • by voluntary written informed consent and has received a signed and dated copy of
  • the informed consent form.
  • 6. Females of childbearing potential, using an effective contraceptive method for at least
  • one month before the beginning of the study, and willing to use throughout the study.

排除标准

  • 1. Volunteers having recent history (within one year) of alcohol or other substance abuse
  • as determined by medical history.
  • 2. Participation in another clinical study or receipt of an investigational drug within 30
  • days of the screening visit.
  • 3. Previous participation in similar study with similar products.
  • 4. Volunteer has any visible skin disease at the site of application that, in the opinion of
  • the investigator, will interfere with the skin assessments.
  • 5. Volunteer has current or relevant previous history of serious, severe or unstable
  • physical or psychiatric illness, or medical disorders, such as current or previous
  • history of hepatic or renal diseases (impairment) or peptic ulcer as determined by
  • medical history.
  • 6. Volunteer has a history of hypersensitivity (e.g. asthma, bronchospasm, rhinitis,
  • urticaria, nasal polyps) to aspirin, diclofenac, other NSAIDs, menthol or any of the
  • excipients in the test product(s).
  • 7. Volunteer is receiving systemic or topical NSAIDs, other oral or topical analgesics or
  • antihistamine within 3 days of visit 1, or other medication (such as corticosteroid
  • within 3 weeks of visit 1) which, in the opinion of the investigative personnel, will
  • interfere with the study results.
  • 8. Female volunteers who are pregnant, planning to become pregnant during the study,
  • or are breast-feeding.
  • 9. Female volunteers who have positive pregnancy test.
  • 10. Volunteers who are employees of the sponsor or study site or an immediate family
  • member (e.g. partner, offspring, parents, siblings or siblingâ??s offspring) of such
  • 11. Any skin disorder at the test site that in the investigatorâ??s judgement can affect the
  • readings of the test result
  • 12. Any concomitant medications that in the investigatorâ??s judgement can confound or
  • alter test results or evaluation of adverse events.

研究者

发起方
GSK Consumer Healthcare

相似试验